While therapy for good-prognosis head and neck cancer (HNC) achieves a high rate of cure, current therapy for poor prognosis HNC such as non-resectable cancer is unsatisfactory with local-regional (LR) control rates around 50% after chemo-irradiation, representing the major failure pattern in these patients. Multiple studies have demonstrated that lack of tumor perfusion observed by dynamic contrast-enhanced MRI (DCE-MRI), and low diffusion observed on diffusion-weighed MRI (DW-MRI), representing both lack of tumor membrane disruption and high tumor cellularity, are each associated with higher rates of LR failure rates following therapy. We propose to use these functional imaging modalities to guide intensifying of radiotherapy to tumor sub-volumes predicted to be resistant to therapy, in order to overcome resistance and improve LR tumor control, which will improve disease-free and potentially overall survival in these patients.
Aim 1 is to conduct a randomized phase II study comparing intensification of the radiation doses to the tumor sub-volumes demonstrating poor perfusion early after the start of chemo-radiation.
Aim 2 is to investigate the optimal integration of DW-MRI with DCE-MRI in determining the resistant tumor sub-volumes, and Aim 3 is to investigate functional MRI as a predictor of late damage of the swallowing organs, in order to individualize the sparing of these organs aiming to reduce treatment-related dysphagia based on each patient's sensitivity to radiotherapy. If successful, the results of Aims 2 and 3 wil be incorporated in the clinical study in later years. IMPACT: As DCE-MRI and DW-MRI are widely available in the community, the proposed studies will lead to future multi- institutional study which will assess the improvements in LR control rates and DFS in advanced HNC promised by the proposed concepts and investigations.

Public Health Relevance

While treatment of good-prognosis head and neck cancer (HNC) has achieved a high cure rates, local-regional failure rates in locally advanced, poor-prognosis HNC are still high. Various metabolic, physiological and molecular imaging modalities have a prognostic value in HNC. We will use physiological MRI before and early during chemo-irradiation to identify parts of the tumors which are likely resistant to therapy, and will intensiy the radiation doses to these parts to overcome resistance. We will test this approach against standard therapy, and will also use physiological MRI to further improve targeting of the resistant tumor parts while reducing the toxicity of therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA184153-03
Application #
9212122
Study Section
Clinical Oncology Study Section (CONC)
Program Officer
Vikram, Bhadrasain
Project Start
2015-03-01
Project End
2020-02-29
Budget Start
2017-03-01
Budget End
2018-02-28
Support Year
3
Fiscal Year
2017
Total Cost
$438,386
Indirect Cost
$147,006
Name
University of Michigan Ann Arbor
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Teng, Feifei; Aryal, Madhava; Lee, Jae et al. (2018) Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers. Int J Radiat Oncol Biol Phys 102:969-977
Hawkins, Peter G; Kadam, Amrut S; Jackson, William C et al. (2018) Organ-Sparing in Radiotherapy for Head-and-Neck Cancer: Improving Quality of Life. Semin Radiat Oncol 28:46-52
Manohar, Poorni M; Beesley, Lauren J; Bellile, Emily L et al. (2018) Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer. Clin Nucl Med 43:641-647
Rosen, Benjamin S; Hawkins, Peter G; Polan, Daniel F et al. (2018) Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy. Int J Radiat Oncol Biol Phys 102:1319-1329
Teng, Feifei; Tsien, Christina I; Lawrence, Theodore S et al. (2017) Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapy. Radiother Oncol 125:89-93
You, Daekeun; Aryal, Madhava; Samuels, Stuart E et al. (2016) Temporal Feature Extraction from DCE-MRI to Identify Poorly Perfused Subvolumes of Tumors Related to Outcomes of Radiation Therapy in Head and Neck Cancer. Tomography 2:341-352
Samuels, Stuart E; Vainshtein, Jeffrey; Spector, Matthew E et al. (2015) Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy. Radiother Oncol 116:75-81